Larimar Therapeutics Reports Second Quarter 2026 Financial and Business Update

Go back to Larimar Therapeutics Reports Second Quarter 2026 Financial and Business Update
(NASDAQ: LRMR) Delayed: 2.70 --0 (-0%)
Previous Close $2.70    52 Week High $ 
Open $2.70    52 Week Low $ 
Day High $2.70    P/E N/A 
Day Low $2.70    EPS $ 
Volume 50